Apple is entering the brain-machine field: developing control of the iPhone through neural signals

According to reports, Apple Inc. (AAPL.US) is attempting to integrate a technology that allows humans to control their iPhones using neural signals. The media states that Apple is collaborating with the startup Synchron to develop a new type of brain-computer interface to assist disabled individuals in using their devices.

Synchron is a private company that develops implantable neural interface solutions, similar to Elon Musk's Neuralink. Synchron offers a device called Stentrode, which integrates electrodes that read brain signals. Since 2019, Stentrode devices have been implanted in 10 individuals, indicating that the technology is still in the early stages of development.

By integrating this technology into its devices, Apple could open doors for thousands of users who are paralyzed or suffer from amyotrophic lateral sclerosis.

Brain-computer interface technology has garnered significant attention in the global medical field and is seen as one of the important development directions for future healthcare. McKinsey estimates that the potential market size for brain-computer interface applications in healthcare could reach $40 billion to $145 billion between 2030 and 2040.

Neuralink recently opened patient registration globally. It offers an implant similar to Stentrode, called Blindsight, which is expected to be implanted in human patients for the first time by the end of 2025. In January of this year, Musk stated that 20 to 30 patients could receive upgraded versions of the experimental brain-computer implants developed by Neuralink this year